participants in just over 8-months' time. And while this is a testament to the Watch's value as a clinical research recruitment tool, the final results of that landmark study also came out last week — and they weren't entirely positive: Over 3,000 people were that they may be at risk for Afib but were subsequently diagnosed with the condition by healthcare professionals.
since 2010, and startups focused on genetics brought in the second most deals across all health areas. with Google-affiliated Verily to bring genetic testing information to the company's Project Baseline research initiative. Genetics likely garners so much attention from big tech because DNA is essentially a data-driven technology, and processing the information contained within DNA could benefit from the processing power of cloud computing power and AI — fields dominated by big tech.
And as companies begin to integrate and research the interplay between genetic information and biometric data, we'll undoubtedly see genetic testing firms and big tech push closer together in the coming years., Business Insider Intelligence's expert product suite keeping you up-to-date on the people, technologies, trends, and companies shaping the future of healthcare, delivered to your inbox 6x a week.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »